Navigation Links
Ameritox(R) Appoints Jay B. Zimmerman as Chief Operating Officer
Date:12/8/2009

BALTIMORE, Dec. 8 /PRNewswire/ -- Ameritox, the U.S. leader in pain medication monitoring solutions, has announced the appointment of Jay B. Zimmerman as Chief Operating Officer. Zimmerman will oversee R&D, infrastructure and expansion initiatives, including driving efficiencies within existing operations, overseeing the development of new technologies, and ensuring process standardization and quality control across all facilities, including the Midland, TX laboratory and the new laboratory opening in Greensboro, NC in 2010. Jay joined Ameritox on September 1, 2009 and will be based at its headquarters in Baltimore, MD.

"Jay is bringing his expertise in building high quality infrastructure and scalability to bear at a critical moment in our growth," said Ancelmo E. Lopes, CEO of Ameritox. "We welcome his leadership as we expand processing capacity with our new laboratory in North Carolina and prepare to launch new technologies that will enhance our current offerings, furthering our ability to provide physicians with critical tools to achieve optimal patient outcomes in Pain Medication Monitoring."

For more than 20 years, Mr. Zimmerman has managed clinical research programs in a variety of settings. He began his career at Massachusetts General Hospital, the flagship Harvard University Hospital, where he served as Administrative Director in the Center for Imaging and Pharmaceutical Research. Mr. Zimmerman was later appointed Senior Vice President and Chief Operating Officer of WorldCare, Inc., a clinical research organization serving Proctor & Gamble, Hoffmann La Roche, Novartis and other leading pharmaceutical companies.

At Perceptive Informatics, Inc., a subsidiary of the biopharmaceutical services provider PAREXEL International, Jay served as Vice President of the Medical Imaging Division. During his tenure there he oversaw the company's contract research and consulting services for pharmaceutical, biotechnology and medical device customers in their use of medical imaging as an endpoint in clinical trials - contributing to dozens of successful regulatory submissions.

Most recently Mr. Zimmerman founded North Point Imaging Research, a start up venture providing technology and services using medical imaging as an endpoint in the clinical development process.

Jay Zimmerman received his Masters of Education in Administrative Policies Studies, Hospital Administration from the University of Pittsburgh, and a Bachelor of Science in Biology/Education from the University of South Carolina.

About Ameritox

Ameritox is the nation's leader in pain medication monitoring solutions(SM), offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provide physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx Guardian(SM), the most thorough and personalized lab service available and the only pain medication testing program with a proprietary methodology to help physicians assess whether patients are taking their pain medication as directed. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, MD, with laboratory facilities in Midland, TX and a second laboratory opening early 2010 in Greensboro NC.

AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.

Contact: Jennifer Paganelli of Edelman PR Worldwide, +1-347-658-8290

SOURCE Ameritox


'/>"/>
SOURCE Ameritox
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Quark Pharmaceuticals Appoints New Chief Medical Officer
2. West Pharmaceutical Services, Inc. Appoints New Director
3. PAREXEL Expands Late Phase Clinical Research Services and Appoints Leading Pharmacoepidemiology Expert Victor Kiri
4. Curemark Appoints Preeminent Pediatrics Gastroenterologist
5. CVBT Appoints Dr. Nabil Dib as Principal Investigator for Phase II Heart Trial
6. Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
7. Cytopia Appoints Study Chairman for JAK2 Clinical Trial
8. Enobia Pharma Appoints Industry Veterans with Commercial and Manufacturing Expertise to Expand Senior Management Team
9. NovaRx Appoints Industry Veteran as President and COO
10. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
11. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/2/2016)... MARLBOROUGH, Mass. , May 2, 2016  While ... effects that osteoporosis can have on their health, only ... 1   according to the results of a new ... ). To mark the start of National Osteoporosis Month, ... women,s health, which affects nearly 56 million Americans. ...
(Date:5/2/2016)... , May 2, 2016 ... to reach USD 11.1 billion by 2024, according ... Research, Inc. Major drivers of the sonography market ... areas and government recommendations for periodic ultrasound screenings ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ...
(Date:4/29/2016)... April 29, 2016 ReportsnReports.com ... 2016" market research report that provides an overview ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
Breaking Medicine Technology:
(Date:5/2/2016)... (PRWEB) , ... May 02, 2016 , ... Pregnancy Awareness ... when trying to conceive. , “If you are ready to have a ... Seibel. “My book, HealthChequesTM: Journal Babies is your Personal Conception & Pregnancy Organizer, ...
(Date:5/2/2016)... ... May 02, 2016 , ... TeleMedCo™, a ... designed to automate and improve the rapid diagnosis, triage and admission of patients ... platform, application, and mobile experience for the first time at GENBAND’s Perspectives16 conference. ...
(Date:5/2/2016)... ... May 02, 2016 , ... Consultative health ... and GM Jim Callandrillo and Duane Reed, VP of business development of AJMC ... Intelligence and Research Group (PBIRG) General Meeting from May 15-17 at the ...
(Date:5/2/2016)... ... May 02, 2016 , ... Atlantic Information Services, Inc. ... Part B Payment Model Could Transform the Pharma Landscape .” CMS recently proposed a ... its spend on provider-administered drugs while preserving care provided to beneficiaries. The webinar will ...
(Date:5/2/2016)... ... 2016 , ... For many artists, the act of blending paint is based ... a science. , Using the new, highly precise METTLER TOLEDO ML204T balance to ... and meaning to his works. What’s more, it has allowed him to recreate these ...
Breaking Medicine News(10 mins):